Detalles de la búsqueda
1.
Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment in Austrian kidney transplant recipients participating in the U-PGx PREPARE study.
Pharmacogenomics J
; 24(2): 10, 2024 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38499549
2.
Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study.
Hum Genomics
; 17(1): 51, 2023 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37287029
3.
Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study.
Pharmacol Res
; 197: 106949, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37802427
4.
Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity.
Am J Hum Genet
; 104(6): 1158-1168, 2019 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31155283
5.
Assessing the utility of measurement methods applied in economic evaluations of pharmacogenomics applications.
Pharmacogenomics
; 25(2): 79-95, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38288576
6.
Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; a telephone survey.
BMC Cardiovasc Disord
; 11: 16, 2011 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-21492471
Resultados
1 -
6
de 6
1
Próxima >
>>